4//SEC Filing
Olek Elizabeth A 4
Accession 0001415889-24-005151
CIK 0001741830other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:12 PM ET
Size
5.2 KB
Accession
0001415889-24-005151
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Olek Elizabeth A
SR VP, CLINICAL SCIENCE
Transactions
- Sale
Common Stock
2024-02-21$1.05/sh−7,368$7,765→ 193,275 total
Footnotes (2)
- [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $1.0539, and the range of prices were between $1.02 to $1.11. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
Kronos Bio, Inc.
CIK 0001741830
Entity typeother
Related Parties
1- filerCIK 0001419066
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:12 PM ET
- Size
- 5.2 KB